Numerous studies have shown that CD8+ T cells modulate CD4+ T cell activation and proliferation in the setting of autoimmunity [36, 37], transplant rejection[38, 39], and anti-tumor immune responses[40, 41]. This evidence concerns the gene CD8A and neoplasm.